{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,13]],"date-time":"2026-01-13T05:20:50Z","timestamp":1768281650317,"version":"3.49.0"},"reference-count":144,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T00:00:00Z","timestamp":1577836800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T00:00:00Z","timestamp":1577836800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinics in Dermatology"],"published-print":{"date-parts":[[2020,1]]},"DOI":"10.1016\/j.clindermatol.2019.10.017","type":"journal-article","created":{"date-parts":[[2019,10,23]],"date-time":"2019-10-23T19:51:19Z","timestamp":1571860279000},"page":"63-78","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"title":["The rash that presents as a red swollen face"],"prefix":"10.1016","volume":"38","author":[{"given":"Mariana","family":"Batista","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Margarida","family":"Gon\u00e7alo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.clindermatol.2019.10.017_bb0005","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1111\/all.12380","article-title":"Classification, diagnosis, and approach to treatment for angioedema: consensus report from the Hereditary Angioedema International Working Group","volume":"69","author":"Cicardi","year":"2014","journal-title":"Allergy"},{"key":"10.1016\/j.clindermatol.2019.10.017_bb0010","doi-asserted-by":"crossref","first-page":"1393","DOI":"10.1111\/all.13397","article-title":"The EAACI\/GA(2)LEN\/EDF\/WAO guideline for the definition, classification, diagnosis and management of urticaria","volume":"73","author":"Zuberbier","year":"2018","journal-title":"Allergy"},{"key":"10.1016\/j.clindermatol.2019.10.017_bb0015","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1111\/joim.12304","article-title":"Presentation, diagnosis and treatment of angioedema without wheals: a retrospective analysis of a cohort of 1058 patients","volume":"277","author":"Mansi","year":"2015","journal-title":"J Intern Med"},{"key":"10.1016\/j.clindermatol.2019.10.017_bb0020","doi-asserted-by":"crossref","first-page":"150","DOI":"10.2500\/aap.2013.34.3640","article-title":"National estimates of emergency department visits for angioedema and allergic reactions in the United States","volume":"34","author":"Kelly","year":"2013","journal-title":"Allergy Asthma Proc"},{"key":"10.1016\/j.clindermatol.2019.10.017_bb0025","doi-asserted-by":"crossref","first-page":"511","DOI":"10.2500\/aap.2010.31.3403","article-title":"The burden of hospitalizations and emergency department visits with hereditary angioedema and angioedema in the United States, 2007","volume":"31","author":"Zilberberg","year":"2010","journal-title":"Allergy Asthma Proc"},{"key":"10.1016\/j.clindermatol.2019.10.017_bb0030","doi-asserted-by":"crossref","first-page":"390","DOI":"10.2500\/aap.2011.32.3478","article-title":"Descriptive epidemiology of hereditary angioedema emergency department visits in the United States, 2006-2007","volume":"32","author":"Zilberberg","year":"2011","journal-title":"Allergy Asthma Proc"},{"key":"10.1016\/j.clindermatol.2019.10.017_bb0035","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1111\/cei.12159","article-title":"A UK national audit of hereditary and acquired angioedema","volume":"175","author":"Jolles","year":"2014","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.clindermatol.2019.10.017_bb0040","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1016\/j.clindermatol.2014.02.019","article-title":"Red face revisited: flushing","volume":"32","author":"Ikizoglu","year":"2014","journal-title":"Clin Dermatol"},{"key":"10.1016\/j.clindermatol.2019.10.017_bb0045","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1042\/cs0870567","article-title":"Plasma kinins increase after angiotensin-converting enzyme inhibition in human subjects","volume":"87","author":"Pellacani","year":"1994","journal-title":"Clin Sci"},{"key":"10.1016\/j.clindermatol.2019.10.017_bb0050","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1056\/NEJM200208223470820","article-title":"Bradykinin-mediated angioedema","volume":"347","author":"Nussberger","year":"2002","journal-title":"N Engl J Med"},{"key":"10.1016\/j.clindermatol.2019.10.017_bb0055","doi-asserted-by":"crossref","first-page":"1772","DOI":"10.1016\/j.jaci.2016.08.050","article-title":"Autoimmune chronic spontaneous urticaria: what we know and what we do not know","volume":"139","author":"Kolkhir","year":"2017","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.clindermatol.2019.10.017_bb0060","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1503\/cmaj.060535","article-title":"Angioedema without urticaria: a large clinical survey","volume":"175","author":"Zingale","year":"2006","journal-title":"CMAJ"},{"key":"10.1016\/j.clindermatol.2019.10.017_bb0065","doi-asserted-by":"crossref","first-page":"460","DOI":"10.2500\/aap.2011.32.3483","article-title":"Clinical and laboratory features of antihistamine-resistant chronic idiopathic urticaria","volume":"32","author":"Magen","year":"2011","journal-title":"Allergy Asthma Proc"},{"key":"10.1016\/j.clindermatol.2019.10.017_bb0070","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/j.clindermatol.2016.02.024","article-title":"Orofacial granulomatosis","volume":"34","author":"Miest","year":"2016","journal-title":"Clin Dermatol"},{"key":"10.1016\/j.clindermatol.2019.10.017_bb0075","doi-asserted-by":"crossref","first-page":"1624","DOI":"10.1161\/HYPERTENSIONAHA.108.110270","article-title":"Angioedema incidence in US veterans initiating angiotensin-converting enzyme inhibitors","volume":"51","author":"Miller","year":"2008","journal-title":"Hypertension"},{"key":"10.1016\/j.clindermatol.2019.10.017_bb0080","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/S0009-9236(96)90161-7","article-title":"Black Americans have an increased rate of angiotensin converting enzyme inhibitor-associated angioedema","volume":"60","author":"Brown","year":"1996","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/j.clindermatol.2019.10.017_bb0085","doi-asserted-by":"crossref","first-page":"1637","DOI":"10.1001\/archinte.165.14.1637","article-title":"Incidence and characteristics of angioedema associated with enalapril","volume":"165","author":"Kostis","year":"2005","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.clindermatol.2019.10.017_bb0090","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1002\/(SICI)1099-1557(199605)5:3<149::AID-PDS222>3.0.CO;2-I","article-title":"Angiotensin converting enzyme inhibitor-associated angioedema: higher risk in blacks than whites","volume":"5","author":"Burkhart","year":"1996","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"10.1016\/j.clindermatol.2019.10.017_bb0095","doi-asserted-by":"crossref","first-page":"1582","DOI":"10.1001\/2013.jamainternmed.34","article-title":"Comparative risk for angioedema associated with the use of drugs that target the renin-angiotensin-aldosterone system","volume":"172","author":"Toh","year":"2012","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.clindermatol.2019.10.017_bb0100","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.amjhyper.2003.09.014","article-title":"Omapatrilat and enalapril in patients with hypertension: the Omapatrilat Cardiovascular Treatment vs. Enalapril (OCTAVE) trial","volume":"17","author":"Kostis","year":"2004","journal-title":"Am J Hypertens"},{"key":"10.1016\/j.clindermatol.2019.10.017_bb0105","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1001\/jama.1997.03550030072037","article-title":"Recurrent angiotensin-converting enzyme inhibitor\u2014associated angioedema","volume":"278","author":"Brown","year":"1997","journal-title":"JAMA"},{"key":"10.1016\/j.clindermatol.2019.10.017_bb0110","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/S0162-3109(99)00107-1","article-title":"Angioedema due to angiotensin-converting enzyme inhibitors","volume":"44","author":"Agostoni","year":"1999","journal-title":"Immunopharmacology"},{"key":"10.1016\/j.clindermatol.2019.10.017_bb0115","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1001\/jama.1988.03410070095035","article-title":"Clinical profile of angioedema associated with angiotensin converting-enzyme inhibition","volume":"260","author":"Slater","year":"1988","journal-title":"JAMA"},{"key":"10.1016\/j.clindermatol.2019.10.017_bb0120","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1097\/ACI.0b013e328362b835","article-title":"Angioedema induced by angiotensin-converting enzyme inhibitors","volume":"13","author":"Campo","year":"2013","journal-title":"Curr Opin Allergy Clin Immunol"},{"key":"10.1016\/j.clindermatol.2019.10.017_bb0125","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.1520\/JFS15129J","article-title":"Asphyxia due to angiotensin converting enzyme (ACE) inhibitor mediated angioedema of the tongue during the treatment of hypertensive heart disease","volume":"46","author":"Dean","year":"2001","journal-title":"J Forensic Sci"},{"key":"10.1016\/j.clindermatol.2019.10.017_bb0130","first-page":"244","article-title":"Life-threatening angio-oedema and death associated with the ACE inhibitor enalapril","volume":"97","author":"Cupido","year":"2007","journal-title":"S Afr Med J"},{"key":"10.1016\/j.clindermatol.2019.10.017_bb0135","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1016\/S0140-6736(00)02596-4","article-title":"Vasopeptidase inhibition and angio-oedema","volume":"356","author":"Messerli","year":"2000","journal-title":"Lancet"},{"key":"10.1016\/j.clindermatol.2019.10.017_bb0140","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1016\/j.annemergmed.2010.03.032","article-title":"Therapeutic efficacy of icatibant in angioedema induced by angiotensin-converting enzyme inhibitors: a case series","volume":"56","author":"Bas","year":"2010","journal-title":"Ann Emerg Med"},{"key":"10.1016\/j.clindermatol.2019.10.017_bb0145","doi-asserted-by":"crossref","first-page":"e60","DOI":"10.2337\/dc12-0574","article-title":"Sitagliptin-associated angioedema","volume":"35","author":"Gosmanov","year":"2012","journal-title":"Diabetes Care"},{"key":"10.1016\/j.clindermatol.2019.10.017_bb0150","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1007\/s10875-015-0228-3","article-title":"Angioedema triggered by medication blocking the renin\/angiotensin system: retrospective study using the French National Pharmacovigilance Database","volume":"36","author":"Faisant","year":"2016","journal-title":"J Clin Immunol"},{"key":"10.1016\/j.clindermatol.2019.10.017_bb0155","doi-asserted-by":"crossref","first-page":"2273","DOI":"10.1097\/HJH.0b013e32834b4b9b","article-title":"Long-term follow-up of 111 patients with angiotensin-converting enzyme inhibitor-related angioedema","volume":"29","author":"Beltrami","year":"2011","journal-title":"J Hypertens"},{"key":"10.1016\/j.clindermatol.2019.10.017_bb0160","doi-asserted-by":"crossref","first-page":"576","DOI":"10.12659\/AJCR.901960","article-title":"Drug-induced inhibition of angiotensin converting enzyme and dipeptidyl peptidase 4 results in nearly therapy resistant bradykinin induced angioedema: a case report","volume":"18","author":"Hahn","year":"2017","journal-title":"Am J Case Rep"},{"key":"10.1016\/j.clindermatol.2019.10.017_bb0165","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1007\/BF00995913","article-title":"Acquired c1-inhibitor deficiencies in lymphoproliferative diseases with serum immunoglobulin abnormalities. A study of three cases","volume":"32","author":"Hauptmann","year":"1976","journal-title":"Blut"},{"key":"10.1016\/j.clindermatol.2019.10.017_bb0170","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/0090-1229(72)90006-2","article-title":"Acquired C1 inhibitor deficiency in lymphosarcoma","volume":"1","author":"Caldwell","year":"1972","journal-title":"Clin Immunol Immunopathol"},{"key":"10.1016\/j.clindermatol.2019.10.017_bb0175","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1182\/blood.V48.4.567.567","article-title":"Acquired angioedema with lymphoproliferative disorder: association of C1 inhibitor deficiency with cellular abnormality","volume":"48","author":"Schreiber","year":"1976","journal-title":"Blood"},{"key":"10.1016\/j.clindermatol.2019.10.017_bb0180","first-page":"523","article-title":"Acquired C1 inhibitor deficiency in a case of lymphosarcoma of the spleen. Reversal of complement abnormalities after splenectomy","volume":"37","author":"Hauptmann","year":"1979","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.clindermatol.2019.10.017_bb0185","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/0162-3109(96)00086-0","article-title":"Activation of factor XII and cleavage of high molecular weight kininogen during acute attacks in hereditary and acquired C1-inhibitor deficiencies","volume":"33","author":"Cugno","year":"1996","journal-title":"Immunopharmacology"},{"key":"10.1016\/j.clindermatol.2019.10.017_bb0190","doi-asserted-by":"crossref","first-page":"3213","DOI":"10.1182\/blood.V89.9.3213","article-title":"Activation of the coagulation cascade in C1-inhibitor deficiencies","volume":"89","author":"Cugno","year":"1997","journal-title":"Blood"},{"key":"10.1016\/j.clindermatol.2019.10.017_bb0195","doi-asserted-by":"crossref","first-page":"1693","DOI":"10.1016\/S0140-6736(97)09137-X","article-title":"Plasma bradykinin in angio-oedema","volume":"351","author":"Nussberger","year":"1998","journal-title":"Lancet"},{"key":"10.1016\/j.clindermatol.2019.10.017_bb0200","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1186\/1710-1492-6-14","article-title":"Acquired angioedema","volume":"6","author":"Cicardi","year":"2010","journal-title":"Allergy Asthma Clin Immunol"},{"key":"10.1016\/j.clindermatol.2019.10.017_bb0205","doi-asserted-by":"crossref","first-page":"354","DOI":"10.2174\/156652410791317066","article-title":"The acquired deficiency of C1-inhibitor: lymphoproliferation and angioedema","volume":"10","author":"Cicardi","year":"2010","journal-title":"Curr Mol Med"},{"key":"10.1016\/j.clindermatol.2019.10.017_bb0210","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1016\/S0002-9343(03)00396-6","article-title":"Clinical and biological distinctions between type I and type II acquired angioedema","volume":"115","author":"Bouillet-Claveyrolas","year":"2003","journal-title":"Am J Med"},{"key":"10.1016\/j.clindermatol.2019.10.017_bb0215","doi-asserted-by":"crossref","first-page":"1491","DOI":"10.1016\/j.jaci.2013.03.034","article-title":"A focused parameter update: hereditary angioedema, acquired C1 inhibitor deficiency, and angiotensin-converting enzyme inhibitor-associated angioedema","volume":"131","author":"Zuraw","year":"2013","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.clindermatol.2019.10.017_bb0220","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1097\/00005792-199207000-00003","article-title":"Hereditary and acquired C1-inhibitor deficiency: biological and clinical characteristics in 235 patients","volume":"71","author":"Agostoni","year":"1992","journal-title":"Medicine"},{"key":"10.1016\/j.clindermatol.2019.10.017_bb0225","doi-asserted-by":"crossref","first-page":"1074","DOI":"10.1111\/j.1398-9995.2012.02853.x","article-title":"Icatibant treatment for acquired C1-inhibitor deficiency: a real-world observational study","volume":"67","author":"Zanichelli","year":"2012","journal-title":"Allergy"},{"key":"10.1016\/j.clindermatol.2019.10.017_bb0230","doi-asserted-by":"crossref","first-page":"72","DOI":"10.2500\/aap.2013.34.3620","article-title":"Ecallantide for treatment of acute attacks of acquired C1 esterase inhibitor deficiency","volume":"34","author":"Patel","year":"2013","journal-title":"Allergy Asthma Proc"},{"key":"10.1016\/j.clindermatol.2019.10.017_bb0235","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1016\/j.iac.2006.08.002","article-title":"Acquired deficiency of the inhibitor of the first complement component: presentation, diagnosis, course, and conventional management","volume":"26","author":"Zingale","year":"2006","journal-title":"Immunol Allergy Clin N Am"},{"key":"10.1016\/j.clindermatol.2019.10.017_bb0240","doi-asserted-by":"crossref","first-page":"1666","DOI":"10.1056\/NEJM199606203342510","article-title":"Hereditary angioedema","volume":"334","author":"Cicardi","year":"1996","journal-title":"N Engl J Med"},{"key":"10.1016\/j.clindermatol.2019.10.017_bb0245","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1016\/S0140-6736(11)60935-5","article-title":"Hereditary angio-oedema","volume":"379","author":"Longhurst","year":"2012","journal-title":"Lancet"},{"key":"10.1016\/j.clindermatol.2019.10.017_bb0250","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1126\/science.148.3672.957","article-title":"Hereditary angioneurotic edema: two genetic variants","volume":"148","author":"Rosen","year":"1965","journal-title":"Science"},{"key":"10.1016\/j.clindermatol.2019.10.017_bb0255","doi-asserted-by":"crossref","first-page":"407","DOI":"10.2500\/aap.2010.31.3394","article-title":"The humanistic burden of hereditary angioedema: impact on health-related quality of life, productivity, and depression","volume":"31","author":"Lumry","year":"2010","journal-title":"Allergy Asthma Proc"},{"key":"10.1016\/j.clindermatol.2019.10.017_bb0260","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1016\/j.anai.2010.01.024","article-title":"Economic costs associated with acute attacks and long-term management of hereditary angioedema","volume":"104","author":"Wilson","year":"2010","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.clindermatol.2019.10.017_bb0265","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1111\/j.1572-0241.2006.00492.x","article-title":"Symptoms, course, and complications of abdominal attacks in hereditary angioedema due to C1 inhibitor deficiency","volume":"101","author":"Bork","year":"2006","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.clindermatol.2019.10.017_bb0270","series-title":"Dermatology","first-page":"304","article-title":"Urticaria and angioedema","volume":"Vol I","author":"Grattan","year":"2018"},{"key":"10.1016\/j.clindermatol.2019.10.017_bb0275","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1016\/j.amjmed.2007.08.021","article-title":"Hereditary angioedema with normal C1 inhibitor: clinical symptoms and course","volume":"120","author":"Bork","year":"2007","journal-title":"Am J Med"},{"key":"10.1016\/j.clindermatol.2019.10.017_bb0280","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.anai.2012.05.022","article-title":"Clinical, biochemical, and genetic characterization of type III hereditary angioedema in 13 Northwest Spanish families","volume":"109","author":"Marcos","year":"2012","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.clindermatol.2019.10.017_bb0285","doi-asserted-by":"crossref","first-page":"1331","DOI":"10.1111\/j.1398-9995.2010.02368.x","article-title":"Type III hereditary angio-oedema: clinical and biological features in a French cohort","volume":"65","author":"Vitrat-Hincky","year":"2010","journal-title":"Allergy"},{"key":"10.1016\/j.clindermatol.2019.10.017_bb0290","doi-asserted-by":"crossref","first-page":"2204","DOI":"10.1172\/JCI105094","article-title":"Action of complement in hereditary angioneurotic edema: the role of C\u20191-esterase","volume":"43","author":"Donaldson","year":"1964","journal-title":"J Clin Invest"},{"key":"10.1016\/j.clindermatol.2019.10.017_bb0295","doi-asserted-by":"crossref","first-page":"S51","DOI":"10.1016\/j.jaci.2004.06.047","article-title":"Hereditary and acquired angioedema: problems and progress: proceedings of the third C1 esterase inhibitor deficiency workshop and beyond","volume":"114","author":"Agostoni","year":"2004","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.clindermatol.2019.10.017_bb0300","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1016\/j.jaci.2011.11.025","article-title":"International consensus and practical guidelines on the gynecologic and obstetric management of female patients with hereditary angioedema caused by C1 inhibitor deficiency","volume":"129","author":"Caballero","year":"2012","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.clindermatol.2019.10.017_bb0305","doi-asserted-by":"crossref","first-page":"1575","DOI":"10.1111\/all.13384","article-title":"The international WAO\/EAACI guideline for the management of hereditary angioedema-The 2017 revision and update","volume":"73","author":"Maurer","year":"2018","journal-title":"Allergy"},{"key":"10.1016\/j.clindermatol.2019.10.017_bb0310","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1186\/1710-1492-6-22","article-title":"HAE international home therapy consensus document","volume":"6","author":"Longhurst","year":"2010","journal-title":"Allergy Asthma Clin Immunol"},{"key":"10.1016\/j.clindermatol.2019.10.017_bb0315","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1007\/s40259-018-0325-y","article-title":"Lanadelumab for the prophylactic treatment of hereditary angioedema with C1 inhibitor deficiency: a review of preclinical and phase I studies","volume":"33","author":"Busse","year":"2019","journal-title":"BioDrugs"},{"key":"10.1016\/j.clindermatol.2019.10.017_bb0320","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1186\/s13023-014-0205-6","article-title":"Frequency of the virilising effects of attenuated androgens reported by women with hereditary angioedema","volume":"9","author":"Zotter","year":"2014","journal-title":"Orphanet J Rare Dis"},{"key":"10.1016\/j.clindermatol.2019.10.017_bb0325","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1097\/TA.0000000000002061","article-title":"Tranexamic acid administration is associated with an increased risk of posttraumatic venous thromboembolism","volume":"86","author":"Myers","year":"2019","journal-title":"J Trauma Acute Care Surg"},{"key":"10.1016\/j.clindermatol.2019.10.017_bb0330","doi-asserted-by":"crossref","first-page":"348","DOI":"10.2500\/aap.2012.33.3585","article-title":"Preprocedural administration of nanofiltered C1 esterase inhibitor to prevent hereditary angioedema attacks","volume":"33","author":"Grant","year":"2012","journal-title":"Allergy Asthma Proc"},{"key":"10.1016\/j.clindermatol.2019.10.017_bb0335","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1111\/j.0105-1873.2006.00746.x","article-title":"Severe allergic hair dye reactions in 8 children","volume":"54","author":"Sosted","year":"2006","journal-title":"Contact Dermatitis"},{"key":"10.1016\/j.clindermatol.2019.10.017_bb0340","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1097\/PEC.0b013e318226df18","article-title":"Contact dermatitis with severe scalp swelling and upper airway compromise due to black henna hair dye","volume":"27","author":"Broides","year":"2011","journal-title":"Pediatr Emerg Care"},{"key":"10.1016\/j.clindermatol.2019.10.017_bb0345","doi-asserted-by":"crossref","first-page":"515.e3","DOI":"10.1016\/j.ajem.2007.08.010","article-title":"Delayed hypersensitivity reaction from black henna tattoo manifesting as severe facial swelling","volume":"26","author":"Shavit","year":"2008","journal-title":"Am J Emerg Med"},{"key":"10.1016\/j.clindermatol.2019.10.017_bb0350","doi-asserted-by":"crossref","first-page":"110","DOI":"10.4168\/aair.2013.5.2.110","article-title":"Anaphylaxis to topically applied sodium fusidate","volume":"5","author":"Park","year":"2013","journal-title":"Allergy Asthma Immunol Res"},{"key":"10.1016\/j.clindermatol.2019.10.017_bb0355","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1111\/j.1600-0536.2006.01140.x","article-title":"Anaphylaxis caused by contact urticaria because of epoxy resins: an extraordinary emergency","volume":"58","author":"Stutz","year":"2008","journal-title":"Contact Dermatitis"},{"key":"10.1016\/j.clindermatol.2019.10.017_bb0360","first-page":"666","article-title":"Dermatologic emergencies in a tertiary hospital: a descriptive study","volume":"107","author":"Bancalari-Diaz","year":"2016","journal-title":"Actas Dermosifiliogr"},{"key":"10.1016\/j.clindermatol.2019.10.017_bb0365","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1111\/j.1365-2133.2005.06588.x","article-title":"Contact dermatitis to hair dyes in a Danish adult population: an interview-based study","volume":"153","author":"Sosted","year":"2005","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.clindermatol.2019.10.017_bb0370","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/j.jid.2015.10.064","article-title":"Prevalence of contact allergy to p-phenylenediamine in the European general population","volume":"136","author":"Diepgen","year":"2016","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.clindermatol.2019.10.017_bb0375","doi-asserted-by":"crossref","first-page":"e292","DOI":"10.1097\/MJT.0b013e318296f141","article-title":"Severe allergic contact dermatitis from temporary \u201cblack henna\u201d coloring of the hair during religious cultural celebrations: three different cases, same history","volume":"23","author":"Glatstein","year":"2016","journal-title":"Am J Ther"},{"key":"10.1016\/j.clindermatol.2019.10.017_bb0380","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1097\/PEC.0000000000000898","article-title":"Severe neck and face edema in an adolescent-delayed hypersensitivity reaction to hair dye","volume":"33","author":"Isik","year":"2017","journal-title":"Pediatr Emerg Care"},{"key":"10.1016\/j.clindermatol.2019.10.017_bb0385","doi-asserted-by":"crossref","DOI":"10.1136\/bcr-2013-202562","article-title":"Severe facial swelling in a pregnant woman after using hair dye","author":"van Genderen","year":"2014","journal-title":"BMJ Case Rep"},{"key":"10.1016\/j.clindermatol.2019.10.017_bb0390","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1111\/cod.12963","article-title":"Facial dermatitis caused by undeclared methylisothiazolinone in a gel mask: is the preservation of raw materials in cosmetics a cause of concern?","volume":"78","author":"Kerre","year":"2018","journal-title":"Contact Dermatitis"},{"key":"10.1016\/j.clindermatol.2019.10.017_bb0395","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1111\/jdv.15267","article-title":"Isothiazolinone derivatives and allergic contact dermatitis: a review and update","volume":"33","author":"Herman","year":"2019","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.clindermatol.2019.10.017_bb0400","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1007\/s12016-018-8717-9","article-title":"Contact dermatitis to cosmetics","volume":"56","author":"Zirwas","year":"2019","journal-title":"Clin Rev Allergy Immunol"},{"key":"10.1016\/j.clindermatol.2019.10.017_bb0405","doi-asserted-by":"crossref","first-page":"82","DOI":"10.3109\/15569527.2013.812106","article-title":"Exuberant connubial allergic contact dermatitis from diphenhydramine","volume":"33","author":"Teixeira","year":"2014","journal-title":"Cutan Ocul Toxicol"},{"key":"10.1016\/j.clindermatol.2019.10.017_bb0410","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1111\/cod.12455","article-title":"Epidemiological data on airborne contact dermatitis - results of the IVDK","volume":"73","author":"Breuer","year":"2015","journal-title":"Contact Dermatitis"},{"key":"10.1016\/j.clindermatol.2019.10.017_bb0415","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1111\/cod.12166","article-title":"Occupational airborne contact dermatitis from benzodiazepines and other drugs","volume":"70","author":"Swinnen","year":"2014","journal-title":"Contact Dermatitis"},{"key":"10.1016\/j.clindermatol.2019.10.017_bb0420","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1111\/j.1600-0536.1991.tb01628.x","article-title":"Allergic contact dermatitis from Dittrichia viscosa (L.) Greuter","volume":"24","author":"Goncalo","year":"1991","journal-title":"Contact Dermatitis"},{"key":"10.1016\/j.clindermatol.2019.10.017_bb0425","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1111\/j.0105-1873.2005.00582.x","article-title":"Severe delayed cutaneous reaction due to Mediterranean jellyfish (Rhopilema nomadica) envenomation","volume":"52","author":"Uri","year":"2005","journal-title":"Contact Dermatitis"},{"key":"10.1016\/j.clindermatol.2019.10.017_bb0430","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.1111\/j.1365-2133.2012.10857.x","volume":"166","year":"2012","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.clindermatol.2019.10.017_bb0435","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1111\/j.1600-0536.1992.tb03281.x","article-title":"Photosensitivity to piroxicam: absence of cross-reaction with tenoxicam","volume":"27","author":"Goncalo","year":"1992","journal-title":"Contact Dermatitis"},{"key":"10.1016\/j.clindermatol.2019.10.017_bb0440","doi-asserted-by":"crossref","first-page":"377","DOI":"10.4103\/0970-9290.57368","article-title":"Chlorhexidine urticaria: a rare occurrence with a common mouthwash","volume":"20","author":"Sharma","year":"2009","journal-title":"Indian J Dent Res"},{"key":"10.1016\/j.clindermatol.2019.10.017_bb0445","series-title":"Contact Urticaria Syndrome","first-page":"159","article-title":"Contact urticaria syndrome from drugs","author":"Goncalo","year":"2014"},{"key":"10.1016\/j.clindermatol.2019.10.017_bb0450","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/j.annder.2010.01.010","article-title":"Contact urticaria induced by hydrolyzed wheat proteins in cosmetics","volume":"137","author":"Olaiwan","year":"2010","journal-title":"Ann Dermatol Venereol"},{"key":"10.1016\/j.clindermatol.2019.10.017_bb0455","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/j.clindermatol.2016.10.015","article-title":"The \u201cred face\u201d: not always rosacea","volume":"35","author":"Dessinioti","year":"2017","journal-title":"Clin Dermatol"},{"key":"10.1016\/j.clindermatol.2019.10.017_bb0460","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1111\/cod.12432","article-title":"European Society of Contact Dermatitis guideline for diagnostic patch testing - recommendations on best practice","volume":"73","author":"Johansen","year":"2015","journal-title":"Contact Dermatitis"},{"key":"10.1016\/j.clindermatol.2019.10.017_bb0465","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1111\/j.1365-2230.2010.03967.x","article-title":"Drug reaction with eosinophilia and systemic symptoms (DRESS): a clinical update and review of current thinking","volume":"36","author":"Walsh","year":"2011","journal-title":"Clin Exp Dermatol"},{"key":"10.1016\/j.clindermatol.2019.10.017_bb0470","doi-asserted-by":"crossref","first-page":"1826","DOI":"10.1172\/JCI113798","article-title":"Anticonvulsant hypersensitivity syndrome. In vitro assessment of risk","volume":"82","author":"Shear","year":"1988","journal-title":"J Clin Invest"},{"key":"10.1016\/j.clindermatol.2019.10.017_bb0475","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.1111\/j.1365-2133.2003.05584.x","article-title":"A 6-month prospective survey of cutaneous drug reactions in a hospital setting","volume":"149","author":"Fiszenson-Albala","year":"2003","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.clindermatol.2019.10.017_bb0480","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.jemermed.2011.05.052","article-title":"Phenytoin-induced drug reaction with eosinophilia and systemic symptoms (DRESS) syndrome: a case report from the emergency department","volume":"44","author":"Oelze","year":"2013","journal-title":"J Emerg Med"},{"key":"10.1016\/j.clindermatol.2019.10.017_bb0485","doi-asserted-by":"crossref","DOI":"10.1136\/bcr-2018-226023","article-title":"Allopurinol-induced DRESS syndrome presented as a cholecystitis-like acute abdomen and aggravated by antibiotics","author":"Batista","year":"2018","journal-title":"BMJ Case Rep"},{"key":"10.1016\/j.clindermatol.2019.10.017_bb0490","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1016\/j.amjmed.2011.01.017","article-title":"The DRESS syndrome: a literature review","volume":"124","author":"Cacoub","year":"2011","journal-title":"Am J Med"},{"key":"10.1016\/j.clindermatol.2019.10.017_bb0495","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1684\/ejd.2010.0821","article-title":"Amoxicillin-induced flare in patients with DRESS (Drug Reaction with Eosinophilia and Systemic Symptoms): report of seven cases and demonstration of a direct effect of amoxicillin on Human Herpesvirus 6 replication in vitro","volume":"20","author":"Mardivirin","year":"2010","journal-title":"Eur J Dermatol"},{"key":"10.1016\/j.clindermatol.2019.10.017_bb0500","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1111\/jdv.13796","article-title":"Patch testing - a valuable tool for investigating non-immediate cutaneous adverse drug reactions to antibiotics","volume":"31","author":"Pinho","year":"2017","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.clindermatol.2019.10.017_bb0505","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1111\/j.1365-2133.2006.07238.x","article-title":"Several herpesviruses can reactivate in a severe drug-induced multiorgan reaction in the same sequential order as in graft-versus-host disease","volume":"155","author":"Kano","year":"2006","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.clindermatol.2019.10.017_bb0510","doi-asserted-by":"crossref","first-page":"46ra62","DOI":"10.1126\/scitranslmed.3001116","article-title":"Drug reaction with eosinophilia and systemic symptoms (DRESS): a multiorgan antiviral T cell response","volume":"2","author":"Picard","year":"2010","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.clindermatol.2019.10.017_bb0515","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.jbspin.2013.05.002","article-title":"DRESS syndrome","volume":"81","author":"Descamps","year":"2014","journal-title":"Jt Bone Spine"},{"key":"10.1016\/j.clindermatol.2019.10.017_bb0520","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.jaip.2013.11.005","article-title":"Fever, rash, and systemic symptoms: understanding the role of virus and HLA in severe cutaneous drug allergy","volume":"2","author":"Pavlos","year":"2014","journal-title":"J Allergy Clin Immunol Pr"},{"key":"10.1016\/j.clindermatol.2019.10.017_bb0525","doi-asserted-by":"crossref","first-page":"S7","DOI":"10.21037\/atm.2018.08.42","article-title":"HLA-B*58:01 is not the only risk factor associated with allopurinol-induced severe cutaneous adverse drug reactions","volume":"6","author":"Gon\u00e7alo","year":"2018","journal-title":"Ann Transl Med"},{"key":"10.1016\/j.clindermatol.2019.10.017_bb0530","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1111\/bjd.12389","article-title":"HLA-B*58:01 is a risk factor for allopurinol-induced DRESS and Stevens-Johnson syndrome\/toxic epidermal necrolysis in a Portuguese population","volume":"169","author":"Goncalo","year":"2013","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.clindermatol.2019.10.017_bb0535","doi-asserted-by":"crossref","first-page":"693.e1","DOI":"10.1016\/j.jaad.2013.01.033","article-title":"DRESS syndrome: Part I. Clinical perspectives","volume":"68","author":"Husain","year":"2013","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.clindermatol.2019.10.017_bb0540","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1097\/PEC.0b013e31828a3854","article-title":"Pediatrician! Do you know the symptoms of DRESS syndrome? A case report of a 4-year-old girl","volume":"29","author":"Irga","year":"2013","journal-title":"Pediatr Emerg Care"},{"key":"10.1016\/j.clindermatol.2019.10.017_bb0545","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1111\/j.1365-2133.2006.07704.x","article-title":"Variability in the clinical pattern of cutaneous side-effects of drugs with systemic symptoms: does a DRESS syndrome really exist?","volume":"156","author":"Kardaun","year":"2007","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.clindermatol.2019.10.017_bb0550","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1111\/j.1365-2133.2007.07807.x","article-title":"The diagnosis of a DRESS syndrome has been sufficiently established on the basis of typical clinical features and viral reactivations","volume":"156","author":"Shiohara","year":"2007","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.clindermatol.2019.10.017_bb0555","doi-asserted-by":"crossref","first-page":"1","DOI":"10.2332\/allergolint.55.1","article-title":"Drug-induced hypersensitivity syndrome (DIHS): a reaction induced by a complex interplay among herpesviruses and antiviral and antidrug immune responses","volume":"55","author":"Shiohara","year":"2006","journal-title":"Allergol Int"},{"key":"10.1016\/j.clindermatol.2019.10.017_bb0560","doi-asserted-by":"crossref","DOI":"10.1155\/2014\/565320","article-title":"HLA associations and clinical implications in T-cell mediated drug hypersensitivity reactions: an updated review","volume":"2014","author":"Cheng","year":"2014","journal-title":"J Immunol Res"},{"key":"10.1016\/j.clindermatol.2019.10.017_bb0565","doi-asserted-by":"crossref","first-page":"1830","DOI":"10.1097\/TP.0000000000001655","article-title":"Acute liver failure\/injury related to drug reaction with eosinophilia and systemic symptoms: outcomes and prognostic factors","volume":"101","author":"Ichai","year":"2017","journal-title":"Transplantation"},{"key":"10.1016\/j.clindermatol.2019.10.017_bb0570","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1111\/j.1600-0536.2009.01659.x","article-title":"Epicutaneous patch testing in drug hypersensitivity syndrome (DRESS)","volume":"62","author":"Santiago","year":"2010","journal-title":"Contact Dermatitis"},{"key":"10.1016\/j.clindermatol.2019.10.017_bb0575","doi-asserted-by":"crossref","first-page":"154.e1","DOI":"10.1016\/j.joms.2017.09.004","article-title":"Periorbital necrotizing fasciitis induced by streptococcus pyogenes: a case report and clarification","volume":"76","author":"Deneubourg","year":"2018","journal-title":"J Oral Maxillofac Surg"},{"key":"10.1016\/j.clindermatol.2019.10.017_bb0580","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1590\/abd1806-4841.20176614","article-title":"Cutaneous mucormycosis","volume":"92","author":"Castrejon-Perez","year":"2017","journal-title":"An Bras Dermatol"},{"key":"10.1016\/j.clindermatol.2019.10.017_bb0585","doi-asserted-by":"crossref","first-page":"e10","DOI":"10.1093\/cid\/ciu296","article-title":"Practice guidelines for the diagnosis and management of skin and soft tissue infections: 2014 update by the Infectious Diseases Society of America","volume":"59","author":"Stevens","year":"2014","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.clindermatol.2019.10.017_bb0590","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1017\/S0950268809990483","article-title":"Staphylococcus aureus is the most common identified cause of cellulitis: a systematic review","volume":"138","author":"Chira","year":"2010","journal-title":"Epidemiol Infect"},{"key":"10.1016\/j.clindermatol.2019.10.017_bb0595","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1111\/j.1468-3083.2006.01657.x","article-title":"Burden of illness of bacterial cellulitis and erysipelas of the leg in the Netherlands","volume":"20","author":"Goettsch","year":"2006","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.clindermatol.2019.10.017_bb0600","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1159\/000104262","article-title":"Epidemiology and comorbidity of erysipelas in primary care","volume":"215","author":"Bartholomeeusen","year":"2007","journal-title":"Dermatology"},{"key":"10.1016\/j.clindermatol.2019.10.017_bb0605","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1097\/MAJ.0b013e31820e811a","article-title":"Streptococcus pneumoniae soft tissue infections in human immunodeficiency virus","volume":"342","author":"Khan","year":"2011","journal-title":"Am J Med Sci"},{"key":"10.1016\/j.clindermatol.2019.10.017_bb0610","doi-asserted-by":"crossref","first-page":"1754","DOI":"10.1093\/cid\/cit122","article-title":"Clinical trial: comparative effectiveness of cephalexin plus trimethoprim-sulfamethoxazole versus cephalexin alone for treatment of uncomplicated cellulitis: a randomized controlled trial","volume":"56","author":"Pallin","year":"2013","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.clindermatol.2019.10.017_bb0615","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1001\/jama.2016.8825","article-title":"Cellulitis: a review","volume":"316","author":"Raff","year":"2016","journal-title":"JAMA"},{"key":"10.1016\/j.clindermatol.2019.10.017_bb0620","doi-asserted-by":"crossref","first-page":"157","DOI":"10.2165\/00128071-200304030-00002","article-title":"Erysipelas: recognition and management","volume":"4","author":"Bonnetblanc","year":"2003","journal-title":"Am J Clin Dermatol"},{"key":"10.1016\/j.clindermatol.2019.10.017_bb0625","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1111\/j.1365-4632.2010.04464.x","article-title":"Analysis of epidemiology, clinical features and management of erysipelas","volume":"49","author":"Krasagakis","year":"2010","journal-title":"Int J Dermatol"},{"key":"10.1016\/j.clindermatol.2019.10.017_bb0630","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/j.jinf.2004.12.010","article-title":"Erysipelas and cellulitis: clinical and microbiological spectrum in an Italian tertiary care hospital","volume":"51","author":"Lazzarini","year":"2005","journal-title":"J Infect"},{"key":"10.1016\/j.clindermatol.2019.10.017_bb0635","doi-asserted-by":"crossref","first-page":"704","DOI":"10.5021\/ad.2016.28.6.704","article-title":"Serum procalcitonin level reflects the severity of cellulitis","volume":"28","author":"Noh","year":"2016","journal-title":"Ann Dermatol"},{"key":"10.1016\/j.clindermatol.2019.10.017_bb0640","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.jinf.2011.11.004","article-title":"A systematic review of bacteremias in cellulitis and erysipelas","volume":"64","author":"Gunderson","year":"2012","journal-title":"J Infect"},{"key":"10.1016\/j.clindermatol.2019.10.017_bb0645","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1186\/s12879-015-1134-2","article-title":"Erysipelas, a large retrospective study of aetiology and clinical presentation","volume":"15","author":"Blackberg","year":"2015","journal-title":"BMC Infect Dis"},{"key":"10.1016\/j.clindermatol.2019.10.017_bb0650","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1016\/S1064-9689(21)00363-9","article-title":"MR imaging of soft-tissue infection","volume":"3","author":"Beltran","year":"1995","journal-title":"Magn Reson Imaging Clin N Am"},{"key":"10.1016\/j.clindermatol.2019.10.017_bb0655","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.jinf.2012.03.013","article-title":"Risk factors for clinical failure in patients hospitalized with cellulitis and cutaneous abscess","volume":"65","author":"Halilovic","year":"2012","journal-title":"J Infect"},{"key":"10.1016\/j.clindermatol.2019.10.017_bb0660","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.clindermatol.2013.05.037","article-title":"The red face revisited: connective tissue disorders","volume":"32","author":"Kazandjieva","year":"2014","journal-title":"Clin Dermatol"},{"key":"10.1016\/j.clindermatol.2019.10.017_bb0665","doi-asserted-by":"crossref","first-page":"2023","DOI":"10.1002\/ccr3.1741","article-title":"Sarcoidosis presenting with facial swelling (Heerfordt syndrome)","volume":"6","author":"Maharaj","year":"2018","journal-title":"Clin Case Reports"},{"key":"10.1016\/j.clindermatol.2019.10.017_bb0670","doi-asserted-by":"crossref","first-page":"205","DOI":"10.29021\/spdv.76.2.844","article-title":"Qual o seu diagn\u00f3stico? Infiltra\u00e7\u00e3o cut\u00e2neo-mucosa perioral. Dermatology quiz. Perioral mucocutaneous infiltration","volume":"76","author":"Batista","year":"2018","journal-title":"Rev SPDV"},{"key":"10.1016\/j.clindermatol.2019.10.017_bb0675","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/j.jaut.2013.11.005","article-title":"The clinical features, diagnosis and classification of dermatomyositis","volume":"48-49","author":"Iaccarino","year":"2014","journal-title":"J Autoimmun"},{"key":"10.1016\/j.clindermatol.2019.10.017_bb0680","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1186\/s12948-018-0084-9","article-title":"Bench to bedside review of myositis autoantibodies","volume":"16","author":"Palterer","year":"2018","journal-title":"Clin Mol Allergy"},{"key":"10.1016\/j.clindermatol.2019.10.017_bb0685","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1007\/s12016-017-8652-1","article-title":"Cutaneous manifestations of dermatomyositis: a comprehensive review","volume":"53","author":"Mainetti","year":"2017","journal-title":"Clin Rev Allergy Immunol"},{"key":"10.1016\/j.clindermatol.2019.10.017_bb0690","doi-asserted-by":"crossref","first-page":"1178","DOI":"10.1001\/archdermatol.2012.2596","article-title":"The heliotrope sign of dermatomyositis: the correct meaning of the term heliotrope","volume":"148","author":"Russo","year":"2012","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.clindermatol.2019.10.017_bb0695","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1016\/j.jaad.2017.12.010","article-title":"Anti-melanoma differentiation-associated gene 5 (MDA5) dermatomyositis: a concise review with an emphasis on distinctive clinical features","volume":"78","author":"Kurtzman","year":"2018","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.clindermatol.2019.10.017_bb0700","article-title":"A import\u00e2ncia dos novos autoanticorpos espec\u00edficos da dermatomiosite","volume":"1","author":"Calv\u00e3o","year":"2019","journal-title":"Rev SPDV"},{"key":"10.1016\/j.clindermatol.2019.10.017_bb0705","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.jaad.2008.02.043","article-title":"The treatment and prognosis of dermatomyositis: an updated review","volume":"59","author":"Iorizzo","year":"2008","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.clindermatol.2019.10.017_bb0710","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1080\/09546630310018509","article-title":"Topical tacrolimus 0.1% ointment for refractory skin disease in dermatomyositis: a pilot study","volume":"15","author":"Hollar","year":"2004","journal-title":"J Dermatolog Treat"},{"key":"10.1016\/j.clindermatol.2019.10.017_bb0715","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1001\/archderm.141.7.855","article-title":"Combination antimalarials in the treatment of cutaneous dermatomyositis: a retrospective study","volume":"141","author":"Ang","year":"2005","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.clindermatol.2019.10.017_bb0720","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1111\/j.1600-0781.2004.00115.x","article-title":"Dermatomyositis: comparative studies of cutaneous photosensitivity in lupus erythematosus and normal subjects","volume":"20","author":"Dourmishev","year":"2004","journal-title":"Photodermatol Photoimmunol Photomed"}],"container-title":["Clinics in Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0738081X19301932?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0738081X19301932?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T18:15:35Z","timestamp":1760033735000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0738081X19301932"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,1]]},"references-count":144,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,1]]}},"alternative-id":["S0738081X19301932"],"URL":"https:\/\/doi.org\/10.1016\/j.clindermatol.2019.10.017","relation":{},"ISSN":["0738-081X"],"issn-type":[{"value":"0738-081X","type":"print"}],"subject":[],"published":{"date-parts":[[2020,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The rash that presents as a red swollen face","name":"articletitle","label":"Article Title"},{"value":"Clinics in Dermatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clindermatol.2019.10.017","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}